Cite

HARVARD Citation

    Durrani, K. et al. (2019). Authors Reply to Letter to the Editor– In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation". Ocular immunology and inflammation. p. 71. [Online]. 
  
Back to record